Rena Lam

Rena Lam has a diverse work experience spanning over a decade, with their most recent position being the Director of Global Quality Assurance at Mahana Therapeutics. In this role, they built and managed a QA team, obtained ISO certification, and provided quality and regulatory input in product development.

Prior to that, Rena held the position of Director of Quality Assurance at Myriad Women's Health, where they were responsible for the success of various quality assurance teams and played a key role in corporate integration projects.

Before joining Myriad Women's Health, Rena worked at Counsyl and Invitae as a Quality Assurance Manager and Quality Engineer, respectively. In these roles, they focused on process validation, regulatory compliance, and continuous improvement.

Rena's earlier experience includes senior quality specialist roles at Complete Genomics Inc. and a QA officer position at BGI Health. Rena has also worked as a lead technical representative at BGI-Hong Kong Co., Ltd., where they coordinated lab tours and client discussions.

Additionally, Rena has experience as an assistant to the managing director and translator at Glory Master Garment Limited, where they facilitated communication between English and Chinese-speaking personnel and provided support in project management and quality improvement.

Overall, Rena Lam has demonstrated expertise in quality assurance, regulatory compliance, and team management throughout their career.

Rena Lam holds a Bachelor of Arts degree in Molecular and Cell Biology with a focus on Immunology: Infectious Diseases from the University of California, Berkeley. Rena also has a Master of Science degree in Biochemical and Biomedical Sciences from The Chinese University of Hong Kong. Rena has additional certifications including EU MDR (2017/745) Auditor Training from Oriel STAT A MATRIX, ISO 13485:2016 Lead Auditor (TPECS) from BSI, Inspection Team Member Training from the College of American Pathologists (CAP), and Certified Quality Engineer (CQE) from ASQ, obtained in December 2015.